Longitudinal natriuretic peptide measurements tracked left atrial volume changes in ESRD patients, with NT-proBNP best reflecting atrial remodeling over time — a non-invasive monitor for cardiac structural changes.
Key findingLongitudinal natriuretic peptide measurements tracked left atrial volume changes in ESRD patients, with NT-proBNP best reflecting atrial remodeling ov
What the researchers found
Longitudinal natriuretic peptide measurements tracked left atrial volume changes in ESRD patients, with NT-proBNP best reflecting atrial remodeling over time — a non-invasive monitor for cardiac structural changes.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2009.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease.
Hypertension (Dallas, Tex. : 1979), 54(4), 818-24
Citation
Tripepi, Giovanni; Mattace-Raso, Francesco; Mallamaci, Francesca; Benedetto, Francesco Antonio; Witteman, Jacqueline; Malatino, Lorenzo; Zoccali, Carmine. (2009). Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease.. Hypertension (Dallas, Tex. : 1979), 54(4), 818-24. https://doi.org/10.1161/HYPERTENSIONAHA.109.136804